Pacira BioSciences (PCRX) Long-Term Deferred Tax (2020 - 2026)
Pacira BioSciences (PCRX) posted quarterly Long-Term Deferred Tax of $122.1 million for Q1 2026, down 5.34% year-over-year from $129.0 million in Q1 2025, and down 1.4% quarter-over-quarter from $123.9 million in Q4 2025.
Pacira BioSciences (PCRX) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
Pacira BioSciences' Long-Term Deferred Tax history runs 7 years deep, the most recent figure standing at $122.1 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax fell 5.34% year-over-year to $122.1 million; the TTM figure through Mar 2026 stood at $122.1 million (down 5.34% YoY), while the FY2025 annual figure was $123.9 million, down 5.0% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $122.1 million, down from $123.9 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $169.3 million in Q1 2022, with the low at $120.2 million in Q3 2025.
- The 5-year median for Long-Term Deferred Tax is $141.1 million (2024), against an average of $143.3 million.
- The sharpest annual moves came in 2022 and 2024: Long-Term Deferred Tax soared 69.52% in 2022, then fell 15.82% in 2024.
- Pacira BioSciences' Long-Term Deferred Tax stood at $160.3 million in 2022, then slipped by 9.87% to $144.5 million in 2023, then retreated by 9.77% to $130.4 million in 2024, then dropped by 5.0% to $123.9 million in 2025, then decreased by 1.4% to $122.1 million in 2026.
- Business Quant data shows PCRX's Long-Term Deferred Tax at $122.1 million in Q1 2026, $123.9 million in Q4 2025, and $120.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 124.60 Mn |
| Mar 31, 2026 | 122.12 Mn |
| Dec 31, 2025 | 123.85 Mn |
| Sep 30, 2025 | 120.19 Mn |
| Jun 30, 2025 | 128.27 Mn |
| Mar 31, 2025 | 129.01 Mn |
| Dec 31, 2024 | 130.38 Mn |
| Sep 30, 2024 | 134.02 Mn |
| Jun 30, 2024 | 135.14 Mn |
| Mar 31, 2024 | 141.06 Mn |
| Dec 31, 2023 | 144.49 Mn |
| Sep 30, 2023 | 151.66 Mn |
| Jun 30, 2023 | 156.14 Mn |
| Mar 31, 2023 | 167.57 Mn |
| Dec 31, 2022 | 160.31 Mn |
| Sep 30, 2022 | 155.53 Mn |
| Jun 30, 2022 | 167.15 Mn |
| Mar 31, 2022 | 169.28 Mn |
| Dec 31, 2021 | 153.36 Mn |
| Sep 30, 2021 | 93.27 Mn |